180 related articles for article (PubMed ID: 30699430)
41. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
[TBL] [Abstract][Full Text] [Related]
42. The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer.
Kim SP; Shah ND; Karnes RJ; Weight CJ; Frank I; Moriarty JP; Han LC; Borah B; Tollefson MK; Boorjian SA
J Urol; 2012 Jun; 187(6):2011-7. PubMed ID: 22498229
[TBL] [Abstract][Full Text] [Related]
43. Changes in patient characteristics and outcomes for radical cystectomy in England.
Nuttall MC; van der Meulen J; McIntosh G; Gillatt D; Emberton M
BJU Int; 2005 Mar; 95(4):513-6. PubMed ID: 15705070
[TBL] [Abstract][Full Text] [Related]
44. Robotic Intracorporeal Padua Ileal Bladder: Surgical Technique, Perioperative, Oncologic and Functional Outcomes.
Simone G; Papalia R; Misuraca L; Tuderti G; Minisola F; Ferriero M; Vallati G; Guaglianone S; Gallucci M
Eur Urol; 2018 Jun; 73(6):934-940. PubMed ID: 27780643
[TBL] [Abstract][Full Text] [Related]
45. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.
Konety BR; Dhawan V; Allareddy V; Joslyn SA
J Urol; 2005 May; 173(5):1695-700. PubMed ID: 15821560
[TBL] [Abstract][Full Text] [Related]
46. The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
Lee R; Ng CK; Shariat SF; Borkina A; Guimento R; Brumit KF; Scherr DS
BJU Int; 2011 Dec; 108(11):1886-92. PubMed ID: 21501370
[TBL] [Abstract][Full Text] [Related]
47. Association of procedure volume with radical cystectomy outcomes in a nationwide database.
Barbieri CE; Lee B; Cookson MS; Bingham J; Clark PE; Smith JA; Chang SS
J Urol; 2007 Oct; 178(4 Pt 1):1418-21; discussion 1421-2. PubMed ID: 17706712
[TBL] [Abstract][Full Text] [Related]
48. Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study.
Siemens DR; Jaeger MT; Wei X; Vera-Badillo F; Booth CM
World J Urol; 2017 Sep; 35(9):1435-1442. PubMed ID: 28213861
[TBL] [Abstract][Full Text] [Related]
49. Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study.
Catto JWF; Khetrapal P; Ambler G; Sarpong R; Khan MS; Tan M; Feber A; Dixon S; Goodwin L; Williams NR; McGrath J; Rowe E; Koupparis A; Brew-Graves C; Kelly JD
BMJ Open; 2018 Aug; 8(8):e020500. PubMed ID: 30093510
[TBL] [Abstract][Full Text] [Related]
50. Robot-assisted intracorporeal urinary diversion: where do we stand in 2014?
Raza SJ; Tawfeeq M; Al-Daghmin A; Guru KA
Urol Clin North Am; 2014 Nov; 41(4):503-9. PubMed ID: 25306162
[TBL] [Abstract][Full Text] [Related]
51. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting.
Chang SS; Baumgartner RG; Wells N; Cookson MS; Smith JA
J Urol; 2002 Jan; 167(1):208-11. PubMed ID: 11743307
[TBL] [Abstract][Full Text] [Related]
52. Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States.
Mazzone E; Mistretta FA; Knipper S; Tian Z; Larcher A; Widmer H; Zorn K; Capitanio U; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
J Endourol; 2019 Jun; 33(6):438-447. PubMed ID: 30931607
[No Abstract] [Full Text] [Related]
53. Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy.
Zaffuto E; Bandini M; Moschini M; Leyh-Bannurah SR; Gazdovich S; Dell'Oglio P; Gallina A; Shariat SF; Briganti A; Montorsi F; Saad F; Karakiewicz PI
Eur Urol Oncol; 2018 Jun; 1(2):169-175. PubMed ID: 31100242
[TBL] [Abstract][Full Text] [Related]
54. Effect of Uncontrolled Diabetes on Outcomes After Cystectomy in Patients With Bladder Cancer: A Population-Based Study.
Faiena I; Dombrovskiy VY; Sultan RC; Salmasi AH; Singer EA; Weiss RE
Clin Genitourin Cancer; 2016 Oct; 14(5):e509-e514. PubMed ID: 26997576
[TBL] [Abstract][Full Text] [Related]
55. No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care.
Borza T; Jacobs BL; Montgomery JS; Weizer AZ; Morgan TM; Hafez KS; Lee CT; Li BY; Min HS; He C; Gilbert SM; Helm JE; Lavieri MS; Hollenbeck BK; Skolarus TA
Urology; 2017 Jun; 104():77-83. PubMed ID: 28267606
[TBL] [Abstract][Full Text] [Related]
56. Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010.
Hounsome LS; Verne J; McGrath JS; Gillatt DA
Eur Urol; 2015 Jun; 67(6):1056-1062. PubMed ID: 25530608
[TBL] [Abstract][Full Text] [Related]
57. Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience.
Matsumoto K; Tabata KI; Hirayama T; Shimura S; Nishi M; Ishii D; Fujita T; Iwamura M
Asian J Surg; 2019 Jan; 42(1):189-196. PubMed ID: 29254869
[TBL] [Abstract][Full Text] [Related]
58. Implementation of the Exeter enhanced recovery programme for patients undergoing radical cystectomy.
Dutton TJ; Daugherty MO; Mason RG; McGrath JS
BJU Int; 2014 May; 113(5):719-25. PubMed ID: 24712746
[TBL] [Abstract][Full Text] [Related]
59. Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?
Sun M; Ravi P; Karakiewicz PI; Sukumar S; Sammon J; Bianchi M; Shariat SF; Jeong W; Ghani KR; Hansen J; Friedman A; Perrotte P; Peabody JO; Menon M; Trinh QD
Urol Oncol; 2014 Jan; 32(1):27.e7-13. PubMed ID: 23403162
[TBL] [Abstract][Full Text] [Related]
60. Impact of Anaesthetist Volume on Radical Cystectomy Outcomes.
Jubber I; Pang KH; Groves R; Reed O; Noon AP; Catto JWF; Cumberbatch MG
Eur Urol Focus; 2021 Jan; 7(1):117-123. PubMed ID: 31072807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
